|
Volumn 2, Issue 3, 2009, Pages 285-292
|
Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENTEROTOXIN RECEPTOR;
GASTROINTESTINAL HORMONE;
GUANYLATE CYCLASE;
GUANYLIN;
NATRIURETIC FACTOR;
RECEPTOR;
UROGUANYLIN;
ANIMAL;
ANTIBODY SPECIFICITY;
CELL PROLIFERATION;
CELL TRANSFORMATION;
COLORECTAL TUMOR;
EPITHELIUM CELL;
GENETICS;
HORMONE SUBSTITUTION;
HUMAN;
INTERPHASE;
LARGE INTESTINE;
METABOLISM;
MOUSE;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
ADMINISTRATION, ORAL;
ANIMALS;
CELL PROLIFERATION;
CELL TRANSFORMATION, NEOPLASTIC;
COLORECTAL NEOPLASMS;
EPITHELIAL CELLS;
GASTROINTESTINAL HORMONES;
GUANYLATE CYCLASE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
INTERPHASE;
INTESTINE, LARGE;
MICE;
NATRIURETIC PEPTIDES;
ORGAN SPECIFICITY;
RECEPTORS, PEPTIDE;
|
EID: 77955869895
PISSN: None
EISSN: 18744702
Source Type: Journal
DOI: 10.2174/1874-470210902030285 Document Type: Review |
Times cited : (15)
|
References (74)
|